Variants in solute carrier SLC26A9 modify prenatal exocrine pancreatic damage in cystic fibrosis

Journal of Pediatrics

Volumn 166, Issue 5, 2015, Pages 1152-1157.e6

  Miller, Melissa R ^a   Soave, David ^a,b   Li, Weili ^a,b   Gong, Jiafen ^a   Pace, Rhonda G ^c   Boëlle, Pierre Yves ^d,e   Cutting, Garry R ^f   Drumm, Mitchell L ^g   Knowles, Michael R ^c   Sun, Lei ^b   Rommens, Johanna M ^a,h   Accurso, Frank ^i,j   Durie, Peter R ^a,b   Corvol, Harriet ^d,k   Levy, Hara ^l,m   Sontag, Marci K ^j,n   Strug, Lisa J ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d SORBONNE UNIVERSITÉ   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ University of Colorado Denver and Children s Hospital Colorado   (United States)

^j CHILDREN S HOSPITAL COLORADO   (United States)

^k ARMAND TROUSSEAU HOSPITAL   (France)

^l MEDICAL COLLEGE OF WISCONSIN   (United States)

^m Children's Hospital of Wisconsin   (United States)

ⁿ Food Science and Human Nutrition   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; SLC26A9 PROTEIN; TRYPSINOGEN; UNCLASSIFIED DRUG; ANTIPORTER; BIOLOGICAL MARKER; CFTR PROTEIN, HUMAN; SLC26A9 PROTEIN, HUMAN;

ALLELE; APICAL MEMBRANE; ARTICLE; BLOOD SAMPLING; CYSTIC FIBROSIS; EXOCRINE PANCREATIC DAMAGE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NEWBORN; NEWBORN SCREENING; PANCREAS DISEASE; PANCREAS SECRETION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; ABNORMALITIES; BLOOD; CELL MEMBRANE; CLINICAL TRIAL; COLORADO; EXOCRINE PANCREAS; FRANCE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MULTICENTER STUDY; MUTATION; QUALITY CONTROL; STATISTICAL MODEL; WISCONSIN;

ANTIPORTERS; BIOMARKERS; CELL MEMBRANE; COLORADO; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MALE; MUTATION; NEONATAL SCREENING; PANCREAS, EXOCRINE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY CONTROL; TRYPSINOGEN; WISCONSIN;

EID: 84928828949     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.01.044     Document Type: Article

References (43)

1. B. Kerem, J. Rommens, J. Buchanan, D. Markiewicz, T. Cox, and A. Chakravarti Identification of the cystic fibrosis gene: genetic analysis Science 245 1989 1073 1080
2. H. Kopelman, M. Corey, K. Gaskin, P. Durie, Z. Weizman, and G. Forstner Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas Gastroenterology 95 1988 349 355
3. H. Kopelman, P. Durie, K. Gaskin, Z. Weizman, and G. Forstner Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis N Engl J Med 312 1985 329 334
4. A. Boue, F. Muller, C. Nezelof, J.F. Oury, F. Duchatel, and Y. Dumez Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis Hum Genet 74 1986 288 297
5. J.R. Imrie, D.G. Fagan, and J.M. Sturgess Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants Am J Pathol 95 1979 697 708
6. E.H. Oppenheimer, and J.R. Esterly Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases Perspect Pediatr Pathol 2 1975 241 278
7. A. Iannucci, K. Mukai, D. Johnson, and B. Burke Endocrine pancreas in cystic fibrosis: an immunohistochemical study Hum Pathol 15 1984 278 284
8. N. Ahmed, M. Corey, G. Forstner, J. Zielenski, L.C. Tsui, and L. Ellis Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas Gut 52 2003 1159 1164
9. M.N. Bronstein, R.J. Sokol, S.H. Abman, B.A. Chatfield, K.B. Hammond, and K.M. Hambidge Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis J Pediatr 120 1992 533 540
10. J.R. Crossley, R.B. Elliot, and P.A. Smith Dried-blood spot screening for cystic fibrosis in the newborn Lancet 313 1979 472 474
11. M.K. Sontag, K.B. Hammond, J. Zielenski, J.S. Wagener, and F.J. Accurso Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes J Pediatr 147 2005 S83 S88
12. P.R. Durie, G.G. Forstner, K.J. Gaskin, D.J. Moore, G.J. Cleghorn, and S.S. Wong Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency Pediatr Res 20 1986 209 213
13. D. Soave, M. Miller, K. Keenan, W. Li, J. Gong, and W. Ip Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study Diabetes 63 2014 2114 2119
14. M.J. Welsh, B.W. Ramsey, F.J. Accurso, and G.R. Cutting Cystic fibrosis C.R. Scrivner, W.S. Sly, B. Childs, B. Valle, The metabolic and molecular bases of inherited disease Vol III 2001 McGraw-Hill, Inc New York 5121 5188
15. M.K. Sontag, M. Corey, J.E. Hokanson, J.A. Marshall, S.S. Sommer, and G.O. Zerbe Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening J Pediatr 149 2006 650 657.e2
16. R.T.L. Couper, M. Corey, D.J. Moore, L.J. Fisher, G.G. Forstner, and P.R. Durie Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency Pediatr Res 32 1992 179 182
17. L. Sun, J.M. Rommens, H. Corvol, W. Li, X. Li, and T.A. Chiang Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis Nat Genet 44 2012 562 569
18. M.J. Rock, G. Hoffman, R.H. Laessig, G.J. Kopish, T.J. Litsheim, and P.M. Farrell Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing J Pediatr 147 2005 S73 S77
19. A. Munck, J.L. Dhondt, C. Sahler, and M. Roussey Implementation of the French nationwide cystic fibrosis newborn screening program J Pediatr 153 2008 228 233.e1
20. F.A. Wright, L.J. Strug, V.K. Doshi, C.W. Commander, S.M. Blackman, and L. Sun Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 Nat Genet 43 2011 539 546
21. A.L. Price, N.J. Patterson, R.M. Plenge, M.E. Weinblatt, N.A. Shadick, and D. Reich Principal components analysis corrects for stratification in genome-wide association studies Nat Genet 38 2006 904 909
22. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M. Ferreira, and D. Bender PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
23. B.A. Lindau-Shepard, and K.A. Pass Newborn screening for cystic fibrosis by use of a multiplex immunoassay Clin Chem 56 2010 445 450
24. P. Lafont, O. Guy-Crotte, C. Paulin, D. Galvain, S. Mertani, and C. Figarella A specific immunoradiometric assay of cationic trypsin(ogen) that does not recognize trypsin-alpha-1-proteinase inhibitor complex Clin Chim Acta 235 1995 197 206
25. Y. Li, C.J. Willer, J. Ding, P. Scheet, and G.R. Abecasis MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes Genet Epidemiol 34 2010 816 834
26. C. Fuchsberger, G.R. Abecasis, and D.A. Hinds minimac2: faster genotype imputation Bioinformatics 2014
27. B. Howie, C. Fuchsberger, M. Stephens, J. Marchini, and G.R. Abecasis Fast and accurate genotype imputation in genome-wide association studies through pre-phasing Nature Genetics 2012
28. N. Fost, and P.M. Farrell A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma Clin Res 37 1989 495 500
29. J. Brouard, I. Lecoq, J.F. Viel, M. Guillot, M. Laurans, and D. Laroche Evaluation of diagnosis and follow-up in screened children with cystic fibrosis in Normandy Arch Pediatr 8 Suppl 3 2001 603 609
30. V. Scotet, M. de Braekeleer, M. Roussey, G. Rault, P. Parent, and M. Dagorne Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis Lancet 356 2000 789 794
31. P.M. Farrell, M.R. Kosorok, A. Laxova, G. Shen, R.E. Koscik, and W.T. Bruns Nutritional benefits of neonatal screening for cystic fibrosis N Engl J Med 337 1997 963 969
32. R Development Core Team R: A language and environment for statistical computing 2011 R Foundation for Statistical Computing Vienna, Austria
33. M.X. Li, J.Y. Yeung, S. Cherny, and P. Sham Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets Hum Genet 131 2012 747 756
34. R.J. Pruim, R.P. Welch, S. Sanna, T.M. Teslovich, P.S. Chines, and T.P. Gliedt LocusZoom: regional visualization of genome-wide association scan results Bioinformatics 26 2010 2336 2337
35. W. Li, D. Soave, M.R. Miller, K. Keenan, F. Lin, and J. Gong Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities Hum Genet 133 2014 151 161
36. L. Fagerberg, B.M. Hallström, P. Oksvold, C. Kampf, D. Djureinovic, and J. Odeberg Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics Mol Cell Proteomics 13 2014 397 406
37. H. Lohi, M. Kujala, S. Makela, E. Lehtonen, M. Kestila, and U. Saarialho-Kere Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9 J Biol Chem 277 2002 14246 14254
38. X. Liu, T. Li, B. Riederer, H. Lenzen, L. Ludolph, and S. Yeruva Loss of Slc26a9 anion transporter alters intestinal electrolyte and HCO3-transport and reduces survival in CFTR-deficient mice Pflugers Arch 2014 1 15
39. M.H. Chang, C. Plata, K. Zandi-Nejad, A. Sindic, C.R. Sussman, and A. Mercado Slc26a9-anion exchanger, channel and Na+ transporter J Membr Biol 228 2009 125 140
40. C.A. Bertrand, R. Zhang, J.M. Pilewski, and R.A. Frizzell SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia J Gen Physiol 133 2009 421 438
41. M. Avella, C. Loriol, K. Boulukos, F. Borgese, and J. Ehrenfeld SLC26A9 stimulates CFTR expression and function in human bronchial cell lines J Cell Physiol 226 2011 212 223
42. L. Li, Y. Zhou, C.J. Bell, M.C. Earley, W.H. Hannon, and J.V. Mei Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen J Med Screen 13 2006 79 84
43. B.L. Therrell Jr., W.H. Hannon, G. Hoffman, J. Ojodu, and P.M. Farrell Immunoreactive trypsinogen (IRT) as a biomarker for cystic fibrosis: Challenges in newborn dried blood spot screening Mol Genet Metab 106 2012 1 6